By achieving production levels measured in multi-Metric Tons (MT) for the key biopolymer ingredient for BAYSE, and at efficiencies demonstrating commercial viability, ZymoChem is paving the way to ...

Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

The European Laboratory Research & Innovation Group (ELRIG) has announced the keynote speakers for Research & Innovation 2025 ...

Immunovant, Inc. (NASDAQ:IMVT) is a biotechnology company that ranks eighth on our list of stocks expected to double in 2025. IMVT has a focus on developing advanced treatments for patients with ...

This is the foundation of Wellbeing International Foundation’s approach, where the science of natural healing is enhanced through cutting-edge biotech. One of the most promising innovations in this ...

York-based biotech firm, the Aptamer Group ... The company, which has developed novel Optimer® binders to enable innovation in the life sciences industry, has also hailed “significant ...

How will the Trump administration approach healthcare regulation? Will generalist investors remain wary of biotech? Can the industry’s expensive pivot into immunology and obesity deliver drugs ...

This trend continues to undermine the growth and success cycle of the biotech industry within Europe, limiting its potential to establish a globally competitive ecosystem,” said Chambon. Chambon also ...

Lilavati Hospital & Research Centre is set to invest Rs 800 crore in a new 300-bed state-of-the-art cancer hospital in Bandra, Mumbai. The facility will span 3,50,000 square feet, close to the ...

The biotech has allocated around one-quarter of the expected IPO monies to advancing the rest of its portfolio. A phase 3 trial of a 23-valent pneumococcal disease vaccine candidate is the biggest ...